P. Kuna (Lodz, Poland), J. Vestbo (Hvidovre, Denmark)
Functional tests during estimation of arterial stiffness in asthma patients
T. Brodskaya, V. Nevzorova, B. Geltser (Vladivostok, Russian Federation)
|   |
Estimation of the central arterial pressure in asthma patients
T. Brodskaya, B. Geltser, V. Nevzorova (Vladivostok, Russian Federation)
| |
Effects of salmeterol on heart rate variability in patients with bronchial asthma and coronary artery disease
E. Petukhova, J. Krasnova, A. Dzizinskii (Irkutsk, Russian Federation)
| |
The study of the damage degree of myocardial coronary blood flow in patients with chronic obstructive pulmonary disease and severe bronchial asthma
M. Kharitonov, Y. Sorokina, S. Shustov, V. Sukhov (Saint-Petersburg, Russian Federation)
| |
Glucocorticoid therapy in male hypophysial gonadal system with bronchial asthma
M. Kharitonov, M. Kuandykova, V. Baranov (Saint-Petersburg, Russian Federation)
| |
Compliance index among patients with mild asthma
V. Kupaev, O. Vakhno, M. Anipchenko, I. Davydkin (Samara, Russian Federation)
| |
Anti-inflammatory effect of budesonide on the central and peripheral airway inflammation in cough-variant and mild bronchial asthma
M. Imaoka, T. Shimoda, R. Kishikawa, S. Shoji, S. Nishima, Y. Obase (Fukuoka, Kurashiki, Japan)
| |
Reduced bone density in inhaled corticosteroids-treated asthmatic patients showing decreased cortisol response to low-dose ACTH test
K. Fujita, S. Kasayama, M. Otsuki, M. Tanemura, A. Miyatake (Hikone, Shiga, Osaka, Japan)
| |
It does matter which inhalative corticosteroids asthmatic patient use! Looking at ICS side effects from users perspective
P. Kuna, M. Kokot (Lodz, Warsaw, Poland)
| |
Immunological effectiveness of N-acetylcystein in complex therapy in severe persistent bronchial asthma patients
Y. Feschenko, L. Iashyna, I. Iliinskaya, J. Matvienko, S. Moskalenko (Kiev, Ukraine)
| |
Influence of N-acetylcystein in complex basic therapy on the dynamics of pulmonary function test indices in severe bronchial asthma patients
Y. Feschenko, L. Iashyna, S. Moskalenko, N. Kramarska, S. Ischuk (Kiev, Ukraine)
| |
Neu-164, a novel antioxidant and anti-inflammatory compound reduces lung inflammation in a murine model of allergic asthma
C. Dick, R. Clayton, M. Laudon, E. Pinner (Glasgow, United Kingdom; Tel Aviv, Israel)
| |
Salt chamber treatment had no effect on fractional exhaled nitric oxide (FeNO) in patients with symptoms suggesting asthma
J. Sandell, J. Hedman, K. Saarinen, T. Haahtela (Joutseno, Lappeenranta, Helsinki, Finland)
| |
Cost-effectiveness of fluticasone/salmeterol inhaler in treatment of moderate and severe bronchial asthma
P. Vorobyev, M. Aksentyeva, M. Smirnova (Moscow, Russian Federation)
| |
Pharma-epidemiology of bronchial asthma (BA) in Russia. The results of the program ²BASIS².
N. Shartanova, N. Ilina (Moscow, Moscow, Russian Federation)
| |
Magnetocardiographic assessment of therapeutic efficacy of β2–agonists and corticosteroids in patients with COPD and bronchial asthma
A. Vasnev, V. Dubynina, Y. Maslennikov (Troitsk, Moscow, Russian Federation)
| |